Skip to main content Skip to footer

Webinar on Wednesday, 22 April 26

Is Sarcopenia the New Smoking?

FREE WEBINAR

Is sarcopenia the new smoking? 

Wednesday 22nd April 2026

7pm- 8pm (AEST)


We are very excited to announce the upcoming webinar jointly hosted by the Australian and New Zealand Head and Neck Cancer Society and Head and Neck Cancer Australia which seeks to answer the question: Is sarcopenia the new smoking?

Loss of skeletal muscle is increasingly recognised as a major determinant of outcomes for patients with Head and Neck Cancer, influencing treatment tolerance, complications, functional recovery and survival. Clinicians are also navigating overlapping and interacting constructs including sarcopenia, malnutrition, cachexia and frailty, which together contribute to patient vulnerability across the cancer care continuum.

This webinar will provide an evidence-based update on muscle health in Head and Neck Cancer, including advances in body composition assessment, emerging treatment implications, and the evolving literature of the impact of sarcopenia on outcomes including survival. The keynote will be followed by a multidisciplinary discussion focused on translating evidence into practice, including practical strategies to optimise outcomes through multidisciplinary care including nutrition and exercise interventions.

Who should attend?
This webinar will be relevant to multidisciplinary clinicians and researchers working in Head and Neck Cancer with an interest in muscle health and its implications for treatment tolerance, functional recovery, and survival, including allied health professionals, nurses, oncologists and surgeons.

International Keynote Speaker

Vickie E Baracos, Professor, Department of Oncology, University of Alberta, Canada

The long-term focus of Dr Baracos’ career is the pathophysiology of skeletal muscle atrophy in an effort that encompasses fundamental and translational research, a clinical research agenda and an international network of strategic collaboration.

Cancer cachexia, a debilitating condition characterised by profound atrophy of skeletal muscle has been her focus since 2003. 

Multidisciplinary Discussion Panel

 

Moderator: Professor Judy Bauer PhD FDA AdvAPD

Professor Judy Bauer is Professor and Discipline Lead of Nutrition & Dietetics within the Department Nutrition, Dietetics and Food. She is a Fellow of Dietitians Australia and an Accredited Practicing Dietitian with over 40 years of clinical, research and academic experience. Judy is recognised internationally for discovery and translational research in nutrition screening, assessment, innovative nutrition intervention programs and development of evidence-based practice guidelines particularly in onlcology and malnutrition.

 

Clinical A/Professor Merran Findlay PhD FDA AdvAPD

Clinical Associate Professor Merran Findlay is a Senior Research Fellow with the SPHERE Cancer Clinical Academic Group at UNSW. An Advanced Accredited Practising Dietitian and Fellow of Dietitians Australia, she has specialised in cancer nutrition care for more than 25 years. Her research focuses on cancer-related malnutrition and sarcopenia in head and neck cancer, data-driven models of care, and research translation. She has led the development and implementation of evidence-based guidelines, serves on the ANZHNCS Board, the COSA Nutrition Group Executive and contributes to the HANCA Community of Practice.

 

A/Professor Brett Hughes B Sc (Med), MBBS (Hons), FRACP

Brett Hughes is a Senior Staff Specialist Medical Oncologist at the Royal Brisbane and Women’s Hospital and The Prince Charles Hospital. He is the current Medical Oncology Research lead in Thoracic and Head & Neck cancers.  He has an active research interest in head & neck cancer, thoracic malignancies and thyroid cancer and has published over 140 articles including practice change work in immunotherapy and targeted therapy.

 

Rishni Perera BBiomed, MSpeechPath, MSPA-CPSP 

Rishni Perera is a Speech Pathologist at Austin Health and a PhD candidate at The University of Queensland. Her clinical work centres on the assessment and management of swallow and communication complications in adult hospitalised patients. Rishni’s doctoral research explores the interplay between sarcopenia, frailty, and dysphagia in head and neck cancer, generating evidence to guide holistic assessment and intervention pathways.

 

Dr Matthew Wallen PhD AES AEP

Dr Matthew Wallen is a Senior Research Fellow in Cancer Survivorship, the Deputy Lead of the Cancer Survivorship Program and a Senior Lecturer in Exercise Science and Clinical Exercise Physiology within the College of Nursing and Health Sciences at Flinders University. His clinical interest focuses on improving outcomes for people living with and beyond cancer.

Sign up to our newsletter